000 06408nam a2200289 4500
001 394851
010 _a9789211482911
090 _a394851
100 _a20171219d2017 y0pory50 ba
101 _aeng
200 _aWorld drug report 2017
_bRecurso eletrónico
210 _aVienna
_cUnited Nations Office on Drugs and Crime (UNODC)
_d2017
215 _a1 CD-ROM
_d12 cm
225 _aUNODC Research
300 _aSete ficheiros num total de 16,8 MB (36, 68, 68, 60, 48, 48, 35 p.) em formato PDF. Editado em cinco partes - "booklets" - para comemoração do 20.º aniversário da criação do WDR.
330 _aBOOKLET 1 - Executive summary — Conclusions and policy implications. Preface. Explanatory notes (ISBN: 978-92-1-148292-8). Executive summary. Who suffers the heaviest burden of disease from drug use? Drug market diversification. The drug market is thriving. Flux in drug flows. Cannabis market developments. Changing business models for drug trafficking and organized crime. Drug crime proceeds damage economies in the long term. Corruption facilitates illicit drug markets, which fuel corruption. Drug trade benefiting some terrorist, insurgent and non-State armed groups. Scarcity of reliable data on terrorism and corruption. Conclusions and policy implications. Glossary. Regional groupings.BOOKLET 2 - Global overview of drug demand and supply : latest trends, cross-cutting issues (ISBN: 978-92-1-148293-5). Preface. Explanatory notes. Key findings. Introduction. A. Extent of drug use. A quarter of a billion people use drugs globally. Problem drug use as reflected in the demand for drug treatment. B. Health impact of drug use. Almost 12 million people worldwide injected drugs in 2015. HIV and hepatitis markedly impact on people who inject drugs. Drug use and tuberculosis. At least 190,000 mostly preventable drug-related deaths in 2015. C. Pharmaceutical opioids. Access to pain medication: key issues and considerations. Misuse of prescription opioids. Use of prescription opioids and heroin in the United States. Misuse of tramadol in Africa and Asia. D. Extent of drug supply. Cultivation and production. After cannabis, cocaine accounts for the largest quantities seized. Drug trafficking over the darknet continues to increase at a fast pace. ANNEX: Annual prevalence of drug use. Number and prevalence of people who inject drugs and those living with HIV. Opium/Heroin. Coca/Cocaine. Cannabis. Glossary. Regional groupings.BOOKLET 3 - Market analysis of plant-based drugs : Opiates, cocaine, cannabis. (ISBN: 978-92-1-148294-2). Preface. Explanatory notes. Key findings. Introduction. A. The opiate market. Global production of opiates increased by around 30 per cent in 2016. Seizures of opiates have decreased in recent years. Most opiates continue to be trafficked along the Balkan route. Seizures of opiates out of South-East Asia on the increase. Seizures of opiates out of Latin America also on the increase. The global opiate market appears stable. B. The cocaine market. Coca bush cultivation on the increased in the last two years. Record cocaine seizures in 2015, trafficked primarily from South America to North America, Western and Central Europe. Global figures on cocaine use mask important regional patterns and trends. Trafficking of cocaine. C. The cannabis market. Cannabis production remains a global phenomenon. Cannabis trafficking. Cannabis use has remained quite stable at the global level in recent years, despite indications that it continues to increase in Africa and Asia. Developments in measures regulating recreational cannabis use in the United States and Uruguay. ANNEX. Glossary. Regional groupings.BOOKLET 4 - Market analysis of synthetic drugs : Amphetamine-type stimulants, new psychoactive substances. (ISBN: 978-92-1-148296-6). Preface. Explanatory notes. Key findings. Introduction. A. Amphetamine-type stimulants. A.1. Amphetamine-type stimulants: market developments. A.2. Methamphetamine: a dynamic global market. A.3. Amphetamine trafficking is spreading. A.4. “Ecstasy”. B. New psychoactive substances and other synthetic drugs. B.1. New psychoactive substances: market developments. B.2. Characteristics of new psychoactive substances users and trends in new psychoactive substances use. B.3. How well-informed are users of new psychoactive substances and how concerned are they about what they are using? B.4. Health risks of new psychoactive substances with stimulant effects. B.5. Synthetic cannabinoids: toxicity and fatalities. B.6. Use of hallucinogenic new psychoactive substances is increasing in South America. B.7. Synthetic opioids: the resurgence of fentanyl and its analogues. B.8. GBL: a ready source of GHB? B.9. Ketamine supply is increasing in South-East Asia. ANNEX. Glossary. Regional groupings.BOOKLET 5 The drug problem and organized crime, illicit financial flows, corruption and terrorism (ISBN: 978-92-1-148297-3). Preface. Explanatory notes.Key findings. Introduction. A. The drug problem and organized crime. Major transformation of organized crime in recent decades. Evolution of links between organized crime and drug trafficking. Drugs remain an important market for organized crime. State responses to drug trafficking groups. B. Drug proceeds and illicit financial flows. Proceeds of drug crime. Laundering drug profits. Cross-border laundering: illicit financial flows. Economic impact of drug money. C. The drug problem and corruption. Importance of assessing levels of corruption. Corruption along the drug supply chain. Prosperity, corruption and drug markets. Closing information gaps. D. Drugs, terrorism and insurgency. Terrorist, insurgent and non-State armed groups. Funding of terrorist, insurgent and non-State armed groups. Drugs and terror attacks. Terror tactics and drug money. Glossary. Regional groupings.Documentos suplementares: Methodology – World Drug Report 2017; World Drug Report2017: Pre-briefing to the Member States.
606 _aTRÁFICO DE DROGA
_9238858
606 _aROTA DE DROGA
_9343871
606 _aPRODUÇÃO DE DROGA
_9321463
606 _aTRATAMENTO DA TOXICODEPENDÊNCIA
_9343339
606 _aESTATÍSTICAS SOBRE DROGA
_9344136
606 _aRELATÓRIO ANUAL
_9299235
710 _aNAÇÕES UNIDAS
_bOffice on Drugs and Crime
_9320900
955 _xOferta